Esperion Therapeutics, Inc. ( ESPR ) continues to execute under a cloud of market skepticism. While the stock has made an impressive recovery from the depths of skepticism in April and May, ESPR remains capped by important technical levelsDr. Duru has blogged about financial markets since the year 2000. A veteran of the dot-com bubble and bust, the financial crisis, and the coronavirus pandemic, he fully appreciates the value in trading and investing around the extremes of market behavior. In this spirit, h ...